Compugen (CGEN) Enterprise Value (2009 - 2026)
Compugen (CGEN) reported Enterprise Value of -$91.8 million for Q1 2026, down 29.13% on a YoY basis from -$129.5 million in Q1 2025, and up 32.71% sequentially from -$136.4 million in Q4 2025.
Compugen (CGEN) Enterprise Value (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Enterprise Value data on file, last reported at -$91.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 29.13% year-over-year to -$91.8 million; the trailing twelve-month figure through Mar 2026 stood at -$91.8 million (down 29.13% YoY), and the FY2025 full-year result was -$136.4 million, down 71.25% from the prior year.
- Enterprise Value improved to -$91.8 million in Q1 2026, from -$136.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$362000.0 in Q4 2022 to a low of -$136.4 million in Q4 2025.
- A 5-year average of -$72.2 million and a median of -$71.1 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 99.69% in 2022 and tumbled 10657.73% in 2023, its largest moves.
- Tracing CGEN's Enterprise Value over 5 years: stood at -$362000.0 in 2022, then plunged by 10657.73% to -$38.9 million in 2023, then slumped by 104.47% to -$79.6 million in 2024, then plunged by 71.25% to -$136.4 million in 2025, then jumped by 32.71% to -$91.8 million in 2026.
- Business Quant data shows CGEN's Enterprise Value at -$91.8 million in Q1 2026, -$136.4 million in Q4 2025, and -$59.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | -91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.75 Mn |
| Dec 31, 2025 | -136.36 Mn |
| Sep 30, 2025 | -59.36 Mn |
| Jun 30, 2025 | -65.00 Mn |
| Mar 31, 2025 | -71.06 Mn |
| Dec 31, 2024 | -79.63 Mn |
| Sep 30, 2024 | -79.57 Mn |
| Jun 30, 2024 | -59.32 Mn |
| Mar 31, 2024 | -69.05 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Sep 30, 2023 | -47.78 Mn |
| Jun 30, 2023 | -61.98 Mn |
| Mar 31, 2023 | -74.32 Mn |
| Dec 31, 2022 | -362,000.00 |
| Sep 30, 2022 | -88.21 Mn |
| Jun 30, 2022 | -97.29 Mn |
| Mar 31, 2022 | -106.82 Mn |
| Dec 31, 2021 | -117.05 Mn |
| Sep 30, 2021 | -102.25 Mn |
| Jun 30, 2021 | -111.09 Mn |